人类多巴胺转运体中的多巴胺再吸收和抑制机制
Yue Li1,2,3, Xianping Wang1,3, Yufei Meng1,3
1Key Laboratory of Biomacromolecules (CAS), National Laboratory of Biomacromolecules, CAS Center for Excellence in Biomacromolecules, Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
Nature
|August 7, 2024
概括
研究人员揭示了人类的多巴胺转运体
科学领域:
- 神经科学
- 结构生物学
- 药理学
背景情况:
- 多巴胺转运体 (DAT) 调节多巴胺神经传递,并与精神运动兴奋剂的滥用有关.
- 之前对人类的DAT结构,基质结合和药物相互作用的了解有限.
研究的目的:
- 阐明人类DAT功能的结构基础,包括基质和药物结合.
- 了解与传送器调节和治疗发展相关的形状变化和药物结合姿势.
主要方法:
- 人类DAT在阿波,多巴胺结合和药物结合状态 (甲基,GBR12909,tropine) 的结晶结构报告.
- 分析了不同的结合模式和构造状态 (封闭,面向外,面向内).
主要成果:
- 在封闭的DAT中,多巴胺结合的详细结构.
- 结构显示药物结合向外 (可卡因) 和向内 (GBR12909,热素) 的状态.
- GBR12909和热素稳定了面向内部的形状,为其机制提供了新的洞察力,与可卡因形成了对比.
结论:
- 提供了一个理解人类DAT传输机制的结构框架.
- 提供关于ADHD药物和DAT抑制剂的结合的见解.
- 奠定了开发DAT相关疾病和成新疗法的基础.
更多相关视频
相关概念视频
Drugs Affecting Neurotransmitter Synthesis
1.3K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
1.3K
Drugs Affecting Neurotransmitter Release or Uptake
1.0K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.0K
Neurochemical Transmission: Sites of Drug Action
2.2K
Neurochemical transmission, the conduction of electrical impulses between neurons mediated by neurotransmitters, plays a vital role in various physiological processes. Autonomic drugs exert their effects by modulating neurotransmission within the autonomic nervous system. For instance, drugs such as hemicholinium block the precursor uptake necessary for synthesizing acetylcholine, an essential autonomic neurotransmitter. Following synthesis, neurotransmitters are stored in vesicles. Metyrosine...
2.2K
Adrenergic Agonists: Indirect-Acting Agents
1.5K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
1.5K
The Significance of Membrane Transport
24.6K
The transport of solutes across the cell membrane is essential for metabolic processes, like maintaining cell size and volume, generating the action potential, exchanging nutrients and gases, etc. Membrane transport can be either passive or active. It can be simple diffusion, facilitated, or mediated transport aided by transport proteins such as transporters and channels.
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
24.6K
Drugs Affecting GI Tract Motility: Dopamine Receptor Antagonists
290
Prokinetic agents are specialized medications that stimulate gastrointestinal (GI) motility, promoting food movement through the GI tract. Dopamine, an inhibitory neurotransmitter, plays a significant role in this process, reducing GI motility and indirectly controlling the speed of digestion. Dopamine receptor antagonists, such as metoclopramide and domperidone, offer a unique advantage as prokinetic agents. By blocking the dopamine receptors, these drugs increase GI motility, improving food...
290


